Tenecteplase is a thrombolytic agent, commonly referred to as a clot-busting drug, indicated for the treatment of acute ST-elevation myocardial infarction (STEMI). This serious form of heart attack occurs when blood flow to the heart is obstructed, primarily affecting the heart's lower chambers. By dissolving unwanted blood clots in the coronary arteries, Tenecteplase helps to restore blood flow, thereby minimizing heart damage and reducing mortality risk. Its clinical relevance lies in its ability to significantly improve patient outcomes in acute coronary events. In summary, Tenecteplase is vital for saving lives during heart attacks.
Tenecteplase acts by selectively binding to fibrin in the thrombus, converting plasminogen to plasmin, which leads to the degradation of fibrin and dissolution of the clot.
No published brands for this salt yet.